Towards Healthcare
Bone Grafts and Substitutes Market Shares | 6.45% CAGR

Bone Grafts and Substitutes Market to Exceed USD 5.95 Bn by 2034

North America led the Bone Grafts and Substitutes Market with a 43% share, while Asia Pacific is anticipated to experience the highest growth rate of 6.04% from 2024 to 2034. The allograft segment was the largest, accounting for 57% of the market by material. However, the synthetic segment is expected to grow the fastest in the coming decade. Spine fusion dominated the market by application in 2023, with the dental segment projected to see the quickest growth in the forecast period.

Bone Grafts and Substitutes Market Size, Segments and Insights

The global bone grafts and substitutes market size was estimated at US$ 2.99 billion in 2023 and is projected to grow to US$ 5.95 billion by 2034, rising at a compound annual growth rate (CAGR) of 6.45% from 2024 to 2034.

Bone Grafts and Substitutes Market Revenue 2023 - 2034

Unlock Infinite Advantages: Subscribe to Annual Membership

Major Key Insights

  • North America dominated the market share by 43% in 2023.
  • Asia Pacific is expected to grow at the fastest rate of 6.04% during the forecast period.
  • By material, the allograft segment held the largest share of the market by 57% in 2023.
  • By material, the synthetic segment is expected to witness the fastest CAGR during the predicted period of 2024-2034.
  • By application, the spine fusion segment captured the largest bone grafts and substitutes market share in 2023.
  • By application, the dental segment is estimated to exhibit the fastest growth during the forecast period.

Bone Grafts and Substitutes Market: Bone Healing

Bone grafts and bone substitutes are increasingly used in revision arthroplasty, fracture nonunion, traumatology, spine surgery, tumor surgery, and infection. The bone grafts and substitutes market provides bone grafts and bone substitutes for all these procedures in order to stabilize fixation and restoration of alignment for proper reconstruction of bones. After blood, bone is the most commonly transplanted tissue, which suggests that the demand for these grafts is high in the healthcare industry. As cases of bone cancer, bone infection, and spine injuries increase, the demand for bone substitutes and grafts is increasing. In the future, with evidence-based research, healthcare researchers and professionals will be able to develop high-quality grafts while ensuring the products are in an affordable range.

How can AI Improve the Bone Grafts and Substitutes Market?

The above infographic showcases different AI models and how they are used in various steps involved in bone grafting. Each AI model has its unique ability, which helps develop high-quality bone grafts and bone substitutes in less time and with more accuracy.

Artificial Intelligence (AI) is significantly contributing to different segments of medical care, such as diagnostics, forecasting, patient monitoring, patient treatment, and so on. In the case of bone tissue engineering, AI plays a significant role in different steps. These steps include screening, modeling, optimization, parameter setting, synthesis, diagnostics, and developing solutions. Implementation of AI significantly reduces treatment and recovery time. As rigorous validation and testing are done in bone tissue engineering, a large amount of data is generated, and a lot of clinical trials are conducted, which leads to difficulty in manual analysis, and the chances of human errors are increased. AI becomes an essential tool in such cases, and the accuracy of overall results is improved.

For instance,

  • In May 2024, with the goal of improving orthopedic therapies, researchers created a synthetic substance that resembles bone via the use of machine learning and 3D printing. This novel substance may eventually take the role of conventional surgical techniques, which would lessen risks and speed up recovery.

Growing Cases of Traffic Accidents Drive the Market

Bone fractures are very common during accidents and have become a public health issue. According to the World Health Organization, every year, there are around 1.3 million deaths, and around 20 to 50 million people are injured due to road accidents. Traffic accidents were in 9th place when it came to deaths, and it is estimated that it will rise to 5th number by the year 2030. This issue has promoted the growth of the bone grafts and substitutes market. During severe accidents, bones are crushed or heavily damaged, making it impossible for the body to heal and reconstruct the bone structure. In such cases, surgeons use new pieces of bone for proper healing.

High Cost: Restrain the Bone Grafts and Substitutes Market

One of the restraining factors for the market’s growth is the high cost of bone grafts and substitutes. There are several reasons why the grafts are expensive. One of the reasons is the materials used in the making of the grafts and substitutes. Some of the materials used are of high quality but are in low amounts. Another reason for the high cost is the process of making the grafts and substitutes. These products cannot be produced in bulk because different injuries and bone issues require different products, which are developed based on the screening and analysis of bone health. Due to the high cost, it is not possible for lower and middle-class people to afford these grafts. The high cost also restrains the growth of the market in developing and underdeveloped countries.

Minimally Invasive Surgeries is the Future of the Market

Bone grafting is one of the surgeries in which a lot of invasion occurs during analysis and bone grafting. It not only leads to long hospital stays and recovery time, but it can also lead to infections and infection-related shock syndrome. Hence, minimally invasive surgeries hold great potential for the growth of the bone grafts and substitutes market. As the name suggests, minimally invasive surgeries use minimal invasion or surgical opening compared to regular surgical openings. For instance, the S.M.A.R.T. Bone Grafting Technique is a novel, minimally invasive procedure that can be used in bone grafting methods. This technique can provide better bone regeneration outcomes along with fewer complications, less pain, and less swelling. It will also reduce hospital stays, which will reduce the overall cost of care and ultimately lead to better patient outcomes and patient satisfaction.

For instance,

  • In March 2022, a producer of cutting-edge biomaterial products, Synergy Biomedical, LLC, announced today the introduction of the Next Generation Minimally Invasive Bone Graft Delivery System, BIOSPHERE® MIS II. With fresh, cutting-edge biomaterial products to add to an already impressive portfolio, Synergy is providing surgeons with more options.

The Allograft Segment Dominated the Market in 2023

Bone Grafts and Substitutes Market Share, By Material, 2023 (%)

By material, the allograft segment held the largest share of the bone grafts and substitutes market share by 57% in 2023. Allograft is dominantly used for bone grafting. In allograft, bone tissue from a donor is used for bone grafting. Allograft usage is heavily regulated throughout the process by the U.S. FDA. The advantages of using allograft are the availability in various sizes and shapes and no host structure sacrifice is needed. Allografts are usually harvested from the tibia, ribs, fibula, and femur.

For instance,

  • In August 2024, the leading provider of regenerative health, LifeNet Health, announced the release of its most recent bone allograft, which was created in association with Johnson & Johnson MedTech. The business intends to enter the market for a demineralized bone matrix (DBM).

The Synthetic Segment is the Fastest Growing

By material, the synthetic segment is expected to witness the fastest CAGR in the bone grafts and substitutes market during the predicted period of 2024-2034. Non-seous artificial materials are utilized as an alternative for bone grafts in synthetic bone grafts. Materials such as polymers, ceramics, metals, and composites are used to make synthetic bone graft material in a laboratory environment. Materials that closely imitate human bone architecture are the most effective for use in synthetic bone grafts. These biomaterials are frequently calcium-based, porous compounds like calcium phosphates. Synthetic grafts are superior to autografts and allografts in several ways, such as their infinite supply, ease of sterilizing, and ease of storage. In addition, synthetic grafts are very inexpensive, widely available, and free from concerns like viral transmission and donor site morbidity.

For instance,

  • In February 2022, a worldwide medical device manufacturer specializing in spine and orthopedics, Orthofix Medical Inc., announced the complete market introduction of OpusTM BA, a synthetic bioactive bone graft solution intended for use in lumbar and cervical spine fusion surgeries.

The Spine Fusion Segment Dominated in 2023

By application, the spine fusion segment captured the largest bone grafts and substitutes market share in 2023. Spinal fusion is one of the most common operations for the neck or back. By 2060, it is anticipated that the number of posterior spinal fusions performed will have increased by 82% to 102%, with patients over 75 years old and women most likely to benefit from this increase in fusion rates. Up to 2040, gains in anterior and posterior cervical decompression and fusion were projected by different research to be 13.3% and 19.3%, respectively.

The Dental Segment is the Fastest Growing

By application, the dental segment is estimated to exhibit the fastest growth in the bone grafts and substitutes market during the forecast period. A dental bone graft could be necessary if further procedures, including dental implants, are needed or if the surrounding teeth and gums are becoming unhealthy due to bone loss. Bone grafting is a common procedure used in dentistry for a number of purposes. Bone transplants are frequently required for clinical dental medical therapies such as periodontal surgery, sinus lift, ridge augmentation, dental implants, and socket preservation.

For instance,

  • In March 2024, the U.S. Food and Drug Administration (FDA) released draft guidelines that provide sponsors of dental bone grafting devices with assistance on how to comply with unique control criteria for these devices by employing animal research. According to the agency, the recommendations are intended to supplement and, in certain cases, replace earlier guidance on the subject.

Growing Geriatric Population Drives North America’s Market

Stacked Graph 0

By region, North America dominated the bone grafts and substitutes market share by 43% in 2023. North America’s market is significantly growing due to countries like the U.S. and Canada. The major factors that contribute to this growth are technological advances, the advanced healthcare system, and the growing awareness among citizens. The U.S. is the major contributor to the growth due to the growing number of spinal injuries among the older population and the growing use of bone grafting.

Bone Grafts and Substitutes Market NA, EU, APAC, LA, MEA Share, 2023 (%)

It is anticipated that by 2050, there will be 80 million people in the U.S. who are 65 years of age or older, up from 54 million in 2014. One With this rise. Correspondingly, the prevalence of degenerative spinal diseases has increased. Two In the upcoming years, there should be a rise in demand for spine surgery as a result of this. Many stakeholders, including patients, doctors, payers, and legislators, are becoming interested in the rising use of lumbar spinal fusion surgeries in the U.S.

Number of Bone Grafts on Annual Basis

Large Patient Pool Drives the Asia Pacific Market

By region, Asia Pacific is expected to grow at the fastest rate of 6.04% during the forecast period. The bone grafts and substitutes market is growing in Asia Pacific due to a large pool of patients, government investment, and growing healthcare infrastructure. The major countries that contribute to the growth of the market are India, China, South Korea, and Japan.

Most of the old population belongs to Asia Pacific. China, India, and Japan have the largest old-age population, and elderly people are more prone to bone injuries due to poor bone health. Spine fusion is the most common surgery done in elderly people, which indicates that more people in Japan will need bone grafting surgeries.

Top Companies in the Bone Grafts and Substitutes Market

  • AlloSource
  • Biogennix
  • OST Laboratories
  • Biobank
  • Paradigm BioDevices, Inc.
  • Smith + Nephew
  • NuVasive, Inc.
  • DePuy Synthes (Johnson & Johnson Inc.)
  • TBF
  • Orthofix US LLC
  • Baxter
  • Stryker
  • Zimmer Biomet
  • Medtronic
  • Geistlich Pharma AG

Innovation by Biogennix in the Bone Grafts and Substitutes Market

Company Name Biogennix
Headquarters Irvine, California, U.S., North America
Recent Development In June 2024, extensive scientific research describing the advanced features of Biogennix's TrelCor bone graft material was published. Biogennix is an osteobiologics firm that specializes in materials for bone transplant surgeries. TrelCor is a novel dual-phase bone transplant with a surface made of nanocrystalline hydroxycarbanoapatite (HCA) that has been specifically designed to promote bone growth.

Innovation by Paradign in the Bone Grafts and Substitutes Market

Company Name Paradigm BioDevices, Inc.
Headquarters Massachusetts, U.S., North America
Recent Development In July 2024, VisiCORE, a revolutionary bone graft harvesting device featuring a transparent collecting tube and exclusive Graft Retention Technology (GRT)TM, is being introduced by Paradigm BioDevices, Inc. for foot and ankle fusion procedures. In addition to minimizing bone graft loss during collection, lowering the number of passes necessary to extract an acceptable amount of bone graft, and reducing donor site flaws, the system allows users to view bone graft harvests in real time.

Recent Developments in the Bone Grafts and Substitutes Market

  • In August 2024, the FDA's 510(k) approval, which Biogennix said it had received, would allow it to broaden the use of its Agilon Moldable and Morpheus Moldable bone transplants.
  • In November 2023, the Alveolar Bone Graft (ABG) simulator, the newest high-fidelity surgical device in Smile Train Inc.'s (New York) expanding lineup of cleft surgery simulators, was introduced by Simulare Medical, a branch of Smile Train Inc.
  • In October 2023, the business BONESUPPORTTM, a rising star in orthobiologics for treating bone injuries, announced the release of CERAMENT G, the latest iteration of their ground-breaking antibiotic-eluting bone graft alternative. CERAMENT G has been enhanced to make it easier to use and less harmful to the environment.
  • In April 2023, two new biomaterials were added to ZimVie Inc.'s portfolio: the RegenerOss® Bone Graft Plug and the RegenerOss® CC Allograft Particulate. ZimVie Inc. is a leading worldwide life sciences company in the dentistry and spine sectors. In North America, both grafts are currently accessible.

Segments Covered in the Report

By Material

  • Allograft
    • Demineralized Bone Matrix
    • Others
  • Synthetic
    • Ceramics
      • HAP
      • β-TCP
      • α-TCP
      • Bi-phasic Calcium Phosphates (BCP)
      • Others
    • Composites
    • Polymers
    • Bone Morphogenic Proteins (BMP)

By Application

  • Spinal Fusion
  • Dental
  • Craniomaxillofacial
  • Foot & Ankle
  • Joint Reconstruction
  • Long Bone

By Region

  • North America
    • U.S.
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Thailand
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait
  • Insight Code: 5227
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2024
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.

FAQ's

Since the 1980s, calcium phosphate ceramics, in particular, have been employed extensively because of their resemblance to naturally occurring compact bone HAp crystals.

There are many different types of bone replacements, such as putty, powders, pellets, and coatings for implants such as hydroxyapatite-coated joint prostheses.

National Institutes of Health, WHO, FDA, National Library of Medicine, United Nations, Centers for Disease Control and Prevention, North American Spine Society Journal.